Veterinary oncology deals with diagnosis, treatment, control, and prevention of cancers in pets. It involves radiation therapy, chemotherapy, surgery, immunotherapy, and other targeted therapies. Veterinarians are now able to diagnose and treat cancer in pets via advanced medical techniques and specialized therapies.
Global Veterinary Oncology Market is estimated to be valued at USD 810.5 Mn in 2025 and is expected to reach USD 1,770.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.
Key players operating in the veterinary oncology are Zoetis Inc., Elanco, VetDC, Aratana Therapeutics Inc. With the increasing prevalence of pet cancer and rising spending on pet care, key players in this market are investing in R&D to develop novel cancer therapies.
Over the years, growing number of veterinary hospitals, clinics, and animal healthcare facilities is also contributing to the increasing demand for Veterinary Oncology Market Growth services. Additionally, technological advancements like PET scan, radiation therapy, chemotherapy, and targeted therapies have enabled early diagnosis and effective treatment of various cancers affecting pets.
Market Trends
One of the key trends in the veterinary oncology market is growing use of targeted therapies. Players are developing targeted monoclonal antibodies, kinase inhibitors, immunotherapies that can precisely kill cancer cells while limiting toxicity in normal tissues. Secondly, growing popularity of combination therapies using chemotherapy, surgery, and radiation is enabling improved outcomes in cancer treatment of pets.
Market Opportunities
Rising adoption of pets globally presents significant opportunity for players in this industry. According to recent estimates, over 90 million pets are adopted each year in the US alone. This is expected to drive greater demand for advanced cancer diagnosis and therapies. Secondly, growing pet owner awareness about cancer symptoms, veterinary care, and available treatment options will encourage early diagnosis and intervention in pets.
Impact of COVID-19 on Veterinary Oncology Market Growth
The COVID-19 pandemic has significantly impacted the growth of the veterinary oncology market. During the initial months of the pandemic in 2020, many veterinary clinics closed or limited their services only to emergency procedures due to strict lockdown restrictions imposed by governments worldwide. This led to postponement of therapies and routine checkups for pets diagnosed with cancer. The supply chain disruptions also interrupted the supply of key oncology drugs in some regions.
As restrictions are being eased now, the market is slowly recovering. Many clinics have resumed full services while implementing strict safety protocols. Teleconsultations have also picked up popularity for non-emergency cases. However, concerns around virus exposure at clinics continue to impact the willingness of pet owners to seek cancer therapies. Vaccination drives are helping to gradually allay such fears.
To counter short-term losses, market players are focusing on strengthening their online presence and boosting access to therapies. New partnerships for drug delivery are also being explored. As pandemic restrictions continue to ease, the market is projected to witness steady growth in the forecast period. Wider availability of vaccines is expected to further aid the recovery process by encouraging undelayed treatment seeking. However, any future waves of infections may temporarily impact the market again.
Regional Analysis of Veterinary Oncology Market
The veterinary oncology market in North America holds the largest value share globally, estimated to be over 35% in 2025. Availability of advanced diagnostic technologies and therapies, growing pet healthcare expenditure, and higher awareness about pet cancer among owners have been driving strong growth in the region pre-COVID.
The Asia Pacific region is anticipated to emerge as the fastest-growing market during the forecast period. Rising pet ownership, increasing pet healthcare spending capacity, and growing adoption of western practices are some key factors supporting the oncology market growth. Countries like China, India, and South Korea are expected to offer promising opportunities. While the pandemic has delayed market growth in Asia Pacific markets by 6-12 months, recovery is projected to be faster than other regions owing to effective containment of outbreaks.
Get More Insights On- Veterinary Oncology Market
Get This Report In Japanese Language
Get This Report In Korean Language
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
